StockWatch
·
 Medicinal Chemicals and Botanical Products
OtherSep 28, 2026, 04:35 PM

Natural Alternatives International Reports FY2026 Net Sales of $142.5M

AI Summary

Natural Alternatives International, Inc. (NAI) filed its annual 10-K report. The company reported net sales of $142.5 million for fiscal year 2026, an increase from $129.9 million in fiscal year 2025. Private-label contract manufacturing remains the primary revenue driver, contributing $134.6 million in fiscal year 2026. Patent and trademark licensing revenue was $7.9 million. The company also noted an increase in research and development expenses to $2.3 million. NAI confirmed its status as a non-accelerated filer and smaller reporting company.

Key Highlights

  • NAI is a non-accelerated filer and a smaller reporting company.
  • Aggregate market value of common stock held by non-affiliates was approximately $22,113,000 as of December 31, 2025.
  • As of September 28, 2026, 6,264,847 shares of common stock were outstanding, net of 3,387,059 treasury shares.
  • Net sales for fiscal year 2026 were $142,515,000, an increase from $129,860,000 in fiscal year 2025.
  • Private-label contract manufacturing accounted for $134,615,000 in net sales for fiscal year 2026.
  • Patent and trademark licensing revenue was $7,900,000 in fiscal year 2026.
  • Research and development expenses increased to $2.3 million in fiscal year 2026 from $1.8 million in fiscal year 2025.